ResponseCollaborative transition to a methadone formulation change in British Columbia, Canada
Section snippets
Acknowledgements
The authors would like to thank S. Solven, Deputy Registrar of the College of Pharmacists of British Columbia and Dr. A. McNestry of the College of Physicians and Surgeons of British Columbia for their input and support.
References (3)
- et al.
Communicating risk in the context of methadone formulation changes: A qualitative study of overdose warning posters in Vancouver, Canada
International Journal of Drug Policy
(2016)
Cited by (2)
Outrage and algorithms: Shifting drug-related stigma in a digital world
2023, International Journal of Drug Policy“It's about bloody time”: Perceptions of people who use drugs regarding drug law reform
2019, International Journal of Drug PolicyCitation Excerpt :Research has pointed out the impacts of not including the affected community in drug policy reform. For instance, in 2014 several regulatory reforms in British Columbia, Canada resulted in changes to methadone maintenance treatment to a ten-times more concentrated methadone formulation (‘Methadose’) and restrictions in pharmacy delivery services (Greer, Amlani, & Buxton, 2016; McNeil et al., 2015). While some methadone patient groups were involved in developing community posters about the change, policy reforms and materials given to methadone patients were uninformed by patients themselves (Greer, Amlani et al., 2016, 2016).